New inhaler training device for elderly COPD patients
Part of Lungs & breathing clinical trials.
This trial tests a new training device to help older adults with COPD use their inhaler more correctly. The goal is to see if using the device improves breathing, medication accuracy, and quality of life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 65 or older
- Diagnosed with COPD by a doctor
- Currently using a pressurized metered dose inhaler (pMDI)
- Able to communicate in Mandarin or Taiwanese
- Willing to take part in the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new inhaled powder medicine (TQC3927) against an existing combination inhaler for treating COPD, a lung disease that makes breathing difficult. The goal is to see if the new medicine works as well or better and is safe for people with COPD.
This study tests whether providing inhaler training and phone reminders helps older adults use their medication correctly. You may be eligible if you are 65+, use a metered-dose inhaler, and are being treated for a lung condition.
This study checks how well COPD patients use their daily inhalers and finds ways to improve their technique. It aims to help you get the full benefit of your medication.
This study tests a new three-part asthma inhaler (CHF 5993) in people whose asthma isn't well-controlled even though they're already using two standard asthma medicines together. The goal is to see if adding this new medicine helps control asthma better.
This trial tests a device that briefly opens your airways to help release trapped air after exercise. It may reduce shortness of breath and improve your daily life with COPD.
This study tests how well a digital device that tracks your inhaler use works for people with lung conditions like COPD or asthma. It's a small initial study to see if this approach is helpful.
Hear when a new Chronic Obstructive Pulmonary Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.